Evidence map›Paper›PMID 34408540›Full record

ReviewSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2021

A systematic review on traditional medicine

Zhi Zeng, Rui Tian, Jia Feng, Nian-An Yang, Lin Yuan

Open access · hybridAbstract readReview
In one paragraph

Review in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Investigating Amphoteric 3,4'-Biscoumarin-BasedInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhi ZengHubei Provincial Key Laboratory of Occurrence and Intervention of Rhumatic Disease, Hubei Minzu University, Enshi 445000, China.
Rui TianHubei Provincial Key Laboratory of Occurrence and Intervention of Rhumatic Disease, Hubei Minzu University, Enshi 445000, China.
Jia FengHubei Provincial Key Laboratory of Occurrence and Intervention of Rhumatic Disease, Hubei Minzu University, Enshi 445000, China.
Nian-An YangHubei Provincial Key Laboratory of Occurrence and Intervention of Rhumatic Disease, Hubei Minzu University, Enshi 445000, China.
Lin YuanHubei Provincial Key Laboratory of Occurrence and Intervention of Rhumatic Disease, Hubei Minzu University, Enshi 445000, China.
Minzu University of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemical compositionFolk medicinePharmacological effectToddalia asiatica

Identifiers

PMID34408540
PMCPMC8360773
OpenAlexW3165010298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.